Skip to main content
OpenTrials
Completed

NCT Number: NCT00960011

Comparative Study on Self-adhesive Mesh for Open Inguinal Hernia Repair

Tension-less mesh repair is the most common procedure for inguinal hernia. Conventional heavy weight polypropylene meshes have been reported to stimulate inflammatory reaction and this is responsible for mesh shrinkage and postoperative chronic groin pain. Moreover, the fixation of the mesh with sutures is a tedious procedure and accounts for the majority of the operating time. A self gripping semi-absorbable mesh has been developed for anterior tension free inguinal hernia repair. It has the benefit of light weight property and does not require sutures for fixation. This study aims to compare the outcome of this self-gripping light weight mesh with the conventional heavy weight polypropylene mesh in inguinal hernia repair.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Surgery, The University of Hong Kong

Hong Kong, China

About this study

Tension free mesh repair is the most common procedure for inguinal hernia repair. Conventional heavy weight polypropylene meshes have been reported to stimulate inflammatory reaction and this is responsible for mesh shrinkage when scar tissues are formed. In addition, the mesh requires fixation with sutures and there has been postulation that the fixation technique is related to postoperative chronic groin pain. Therefore, some authors have recommended the use of light-weight meshes and to limit the extent of fixation or to use non-compressive absorbable devices. In order to reduce the complications, a new self-gripping semi-resorbable mesh has been developed for anterior tension-free inguinal hernia repair.

The aim of this study is to compare the difference in operating time for open inguinal hernia repair with conventional prolene mesh and ProgripTM, which is a light-weight mesh with self-adhesive mechanism.

Methodology: Patients present with first episode of inguinal hernia are included into the study. Those with a sizable defect (>3cm defect), bilateral, inguino-scrotal hernia, irreducible, recurrence are excluded from study. Informed consents are signed before procedures and details of randomization are explained. Operations are performed by or under the supervision of specialist surgeons. Standardized inguinal dissection are performed. Randomization is carried out immediately before placement of mesh and after adequate inguinal dissection. PI / co-investigator phone to research assistant and ask for randomization result generated by computer. Total operative time, time from mesh placement to wound closure, blood loss, intra-operative complications, hospital stay, post-operative pain and analgesic used are documented.

Post-operative follow-up: Follow-up on day 14, 3 months, 6 months and 1 year post-op. Pain score, paraesthesia , chronic discomfort / pain, recurrence, seroma formation, testicular atrophy are documented. Thereafter, yearly follow-up is performed at clinic or by telephone to document the recurrence and chronic pain.

Parietene ProGrip™ (PP1208DR/ PP1208DL) Manufacturer: Sofradim Production Material: Monofilaments of polypropylene and polylactic acid (PLA) Color: Clear (undyed) Weight: 80g/m2 (before PLA resorbtion), 40g/m2 (after PLA resorbtion) Poresize: 1.7mm x 1mm

Material detailed description:

Parietene ProGrip™ is the first bio-component mesh comprised of monofilament polyester and a resorbable polylactic acid (PLA) gripping system which perfects true tension-free repair. The microhools cover the entire underside of the material allow complete anchoring of the mesh on the tissue. Self-gripping features also allows a strong and solid self-anchoring fixation and therefore making the hernia sac to fit perfectly to groin anatomy and move less underneath the prosthesis. Therefore, less suture is required and so operative time can be saved. Also less chance of nerve entrapment may cause low postoperative pain.

Surgipro Mesh (SPMM-35) Material: Monofilaments of polypropylene Color: Clear (undyed) Measurement: 15cmx15cm Thickness: 0.57mm

Description:

SURGIPRO Mesh is a non-absorbable, inert, sterile, porous surgical mesh knitted from mono-filament fibers of polypropylene polymer. The mesh exhibits high burst strength and tensile strength. The mesh is knitted in such fashion as to interconnect each mono-filament fiber and provide bi-dimensional elasticity while allowing the mesh to be cut to shape without unraveling.

Actions:

SURGIPRO Mesh is a porous, non-absorbable mesh used to repair or reinforce fascial defects following surgery or trauma and serves to provide additional support to such wounds during and following the wound healing period. Animal studies have shown that the polypropylene mono-filament fibers from which SURGIPRO Mesh is manufactured elicit a minimal acute inflammatory reaction in tissue, which is then followed by gradual encapsulation by fibrous tissue. In-growth of this fibrous tissue is permitted by the porosity of the knitted mesh structure. The mesh remains soft and pliable and the non-absorbable polypropylene fibers comprising the mesh resists loss of tensile strength in vivo.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age above 18 and below 80
  • Male or female patients
  • Unilateral inguinal hernia
  • First occurrence hernia

Exclusion criteria

  • Inguino-scrotal hernia
  • Recurrent inguinal hernia
  • Incarcerated hernia
  • Bilateral inguinal hernia

Treatment and study plan

PROGRIP

Device

Use of PROGRIP mesh for open inguinal hernia repair

Other names: PROGRIP MESH

POLYPROPYLENE

Device

Use of Polypropylene mesh in open inguinal hernia repair

Other names: Polypropylene mesh

Primary outcomes

  1. Operating Time From Skin Incision to Wound Closure

    Time frame: Intra-operative record

    It measures the total operating time of 2 groups, measured from time started the skin incision to time finishing wound closure in terms of minutes.

Secondary outcomes

  1. Mesh Placement Time, Total Operative Time

    Time frame: Intra-operative record

    Time from mesh place to end of operation, and total time of operation

  2. Seroma Formation at First Follow-up

    Time frame: 1 week after operation

    Seroma formation at first follow-up, go by clinical

  3. Overall Recurrence at 6 Years

    Time frame: 6 years after operation

    Overall recurrence at 6 years, including all recurrence

  4. Chronic Pain at 6 Years

    Time frame: 6 years after operation

    Patient with persistent chronic pain sensation at 6 years after operation. It described as painful sensation feeling around the operated site which is persistent and causing disturbance to daily normal life and attracted patients' attention.

  5. Patient With Testicular Atrophy From Post-op to 6 Years After Operation

    Time frame: 6 years after operations

    Patient with testicular atrophy from post-op to 6 years after operation, by clinical examination

  6. Patient With Palpable Mesh at 6 Years After Operation

    Time frame: 6 years after operation

    Patient with clinical palpable mesh at 6 years after operation

  7. Patient With Chronic Discomfort at 6 Years After Operation

    Time frame: 6 years after operation

    Patient with persistent chronic discomfort at 6 years after operation. It described as an unpleasant feeling around the operated site which is persistent and causing disturbance to daily normal life and attracted patients' attention. It is differentiate from pain sensation.

  8. Pain or Discomfort Affecting Daily Activities at 6 Years After Operation

    Time frame: 6 years after operation

    pain or discomfort which affecting daily activities at 6 years after operation

  9. Total Number of Analgesic Used

    Time frame: 1 week after operation

    Total Number of Analgesic Used: Tablets

  10. Wound Pain at Rest at 1 Week After Operation

    Time frame: 1 week after operation

    Visual Analogue Score for measurement of wound pain at rest 1 week after operation

  11. Wound Pain on Coughing at 1 Week After Operation

    Time frame: 1 week after operation

    wound pain on coughingt at 1 week after operation (Visual Analogue Score). It was in the form of 0-10 where 0 is no pain and 10 is maximal pain they experienced in their life. The higher the value, the more painful it is.

  12. Post-operative Stay

    Time frame: 1 week after operation

    Post-operative stay (number of hours)

  13. Days go Outdoor

    Time frame: 1 week after operation

    Post-op number of days that patient can go outdoor

  14. Number of Participants Whose Response Was YES is Reported

    Time frame: 1 week after operation

    Patient will be asked by assessor in out-patient clinic about satisfaction about the whole arrangement of operation. We did not intend to grade the satisfaction but simply ask whether they are satisfied. Will be either YES or NO answer.

  15. Size of Mesh (Longitudinal)

    Time frame: intra-operative record

    Longitudinal size of mesh (in mm).

  16. Size of Mesh (Vertical)

    Time frame: intra-operative record

    Vertical size of mesh (in mm).

  17. Wound Size

    Time frame: intra-operative record

    Size of main wound

Sponsors and collaborators

Lead sponsor

The University of Hong Kong

Other

Collaborators

  • Queen Mary Hospital, Hong Kong
  • Tung Wah Hospital

Registry information

Official study title

Randomized Study of Self Gripping Semi-resorbable Mesh (PROGRIP) With Polypropylene Mesh in Open Inguinal Hernia Repair - the 6 Years Result

Important dates

Study start
2009
Primary completion
2010
Study completion
2016
First posted
Aug 17, 2009
Registry last updated
Apr 15, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.